Quantitation of MHC Tetramer-Positive Cells from Whole Blood: Evaluation of a Single-Platform, Six-Parameter Flow Cytometric Method

Cytometry Part A

Volumn 57, Issue 2, 2004, Pages 120-130

  Wölfl, Matthias ^a   Schalk, Stefan ^a   Hellmich, Martin ^a   Huster, Katharina M ^b   Busch, Dirk H ^b   Berthold, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antigen specific T cells; Cytomegalovirus; Flow cytometry; MHC tetramers; Single platform

Indexed keywords

HLA A ANTIGEN; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CELL COUNT; CYTOMEGALOVIRUS; CYTOMETRY; DIODE LASER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE;

EID: 1042302751     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.10116     Document Type: Article

References (39)

1. Yee C, Greenberg P. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nat Rev Cancer 2002;2:409-419.
2. Klenerman P, Cerundolo V, Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2002;2:263-272.
3. Strike P. Measurement in laboratory medicine: a primer on control and interpretation. Oxford: Butterworth-Heinemann; 1996.
4. Brecher ME, Sims L, Schmitz J, Shea T, Bentley SA. North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J Hematother 1996;5:227-236.
5. Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 1998;34:128-142.
6. Gratama JW, Sutherland DR, Keeney M. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Semin Hematol 2001;38:139-147.
7. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
8. Schnizlein-Bick CT, Mandy FF, O'Gorman MR, Paxton H, Nicholson JK, Hultin LE, et al. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 2002;50:46-52.
9. Bergeron M, Faucher S, Ding T, Phaneuf S, Mandy F. Evaluation of a universal template for single-platform absolute T-lymphocyte subset enumeration. Cytometry 2002;50:62-68.
10. Brocklebank AM, Sparrow RL. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry 2001;46:254-261.
11. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawskl IM, et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002;185:1709-1716.
12. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002;8:362-369.
13. Fontana I, Verrina E, Timitilli A, Arcuri V, Basile G, Losurdo G, et al. Cytomegalovirus infection in pediatric kidney transplantation. Transplant Proc 1994;26:18-19.
14. Hassan-Walker AF, Vargas Cuero AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, et al. CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. J Infect Dis 2001;183:835-843.
15. Sester M, Sester U, Gartner B, Heine G, Girndt M, Mueller-Lantzsch N, et al. Levels of virus-specific CD4 T cells correlate with cytomegalo-virus control and predict virus-induced disease after renal transplantation. Transplantation 2001;71:1287-1294.
16. Singhal S, Shaw JC, Ainsworth J, Hathaway M, Gillespie GM, Paris H, et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation 2000;69:2251-2259.
17. Engstrand M, Tournay C, Peyrat MA, Eriksson BM, Wadstrom J, Wirgart BZ, et al. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 2000;69:2243-2250.
18. Chen FE, Aubert G, Travers P, Dodi LA, Madrigal JA. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy 2002;4:41-48.
19. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001;184:955-963.
20. Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL, Cornelissen JJ. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001;98:1358-1364.
21. Benz C, Utermohlen O, Wulf A, Villmow B, Dries V, Goeser T, et al. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 2002;122:1201-1215.
22. He XS, Rehermann B, Boisvert J, Mumm J, Maecker HT, Roederer M, et al. Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. Viral Immunol 2001;14:59-69.
23. Gratama JW, Cornelissen JJ. Diagnostic potential of tetramer-based monitoring of cytomegalovirus-specific CD8+ T lymphocytes in allogeneic stem cell transplantation. Clin Immunol 2003;106:29-35.
24. Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001;97:1232-1240.
25. Engstrand M, Lidehall AK, Totterman TH, Herrman B, Eriksson BM, Korsgren O. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin Exp Immunol 2003;132:96-104.
26. Gamadia LE, Rentenaar RJ, Baars PA, Remmerswaal EB, Surachno S, Weel JF, et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001;98:754-761.
27. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-1979.
28. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
29. Busch DH, Pilip IM, Vijh S, Pamer EG. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998;8:353-362.
30. McMichael AJ, O'Callaghan CA. A new look at T cells. J Exp Med 1998;187:1367-1371.
31. Schatz PJ. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (NY) 1993;11:1138-1143.
32. Overton WR. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 1988;9:619-626.
33. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160.
34. Chang A, Ma DD. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group. J Hematother 1996;5:605-616.
35. Gratama JW, Kraan J, Keeney M, Granger V, Barnett D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 2002;50:92-101.
36. Bergeron M, Nicholson JK, Phaneuf S, Ding T, Soucy N, Badley AD, et al. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry 2002;50:53-61.
37. Knabel M, Franz TJ, Schiemann M, Wulf A, Villmow B, Schmidt B, et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med 2002;8:631-637.
38. Xu XN, Purbhoo MA, Chen N, Mongkolsapaya J, Cox JH, Meier UC, et al. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class 1/peptide complex. Immunity 2001;14:591-602.
39. Whelan JA, Dunbar PR, Price DA, Purbhoo MA, Lechner F, Ogg GS, et al. Specificity of CTL interactions with peptide-MHC class 1 tetrameric complexes is temperature dependent. J Immunol 1999;163:4342-4348.